Despite all the protective effects of GDF-15, clinical studies in patients with DCM have shown that elevated GDF-15 levels correlate with adverse cardiovascular outcomes, including HF, myocardial infarction, and mortality [99,100]. This evidence concerns the gene GDF15 and hydrops fetalis.